Literature DB >> 11986723

[Relationship between cholinesterase, prothrombin activity and albumin and the pathology of the liver].

Z Zou1, S Xin, B Li.   

Abstract

BACKGROUND: To investigate the relationship between serum cholinesterase, albumin and plasma prothrombin activity and the pathology of the liver in patients with viral hepatitis.
METHODS: Totally 135 patients diagnosed as chronic hepatitis, cirrhosis and/or severe hepatitis with needle biopsy of liver were enrolled in this study. Serum cholinesterase and albumin of the patients were detected with enzyme rate method; meanwhile, their plasma prothrombin activity was detected with turbidimetry test.
RESULTS: The percentage of decrease of the level of serum cholinesterase was higher than that of albumin and plasma prothrombin activity in chronic mild and moderate hepatitis; the level of serum cholinesterase, albumin and plasma prothrombin activity decreased gradually followed by the exacerbation of inflammatory reaction (P<0.001) and by the elevation of degree of fibrosis of the liver (P <0.001) their correlation coefficient was 0.720 to 0.778 (P<0.001).
CONCLUSION: The level of serum cholinesterase could better a nd more sensitively reflect the synthetic function and the damage of the pathology of the liver than that of albumin and plasma prothrombin activity could do, they all negatively correlated with the pathology of the liver.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11986723

Source DB:  PubMed          Journal:  Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi        ISSN: 1003-9279


  2 in total

1.  Assessment of the value of serum cholinesterase as a liver function test for cirrhotic patients.

Authors:  Fanping Meng; Xiaojuan Yin; Xuemei Ma; Xiao-Dong Guo; Bo Jin; Hanwei Li
Journal:  Biomed Rep       Date:  2013-01-21

2.  Total cholesterol level for assessing pancreatic insufficiency due to chronic pancreatitis.

Authors:  Kenji Hirano; Tomotaka Saito; Suguru Mizuno; Minoru Tada; Naoki Sasahira; Hiroyuki Isayama; Miho Matsukawa; Gyotane Umefune; Dai Akiyama; Kei Saito; Shuhei Kawahata; Naminatsu Takahara; Rie Uchino; Tsuyoshi Hamada; Koji Miyabayashi; Dai Mohri; Takashi Sasaki; Hirofumi Kogure; Natsuyo Yamamoto; Yosuke Nakai; Kazuhiko Koike
Journal:  Gut Liver       Date:  2014-04-23       Impact factor: 4.519

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.